| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/24/2023 | — | HSBC | Upgrades | Reduce → Hold | |
| 10/11/2023 | 21.58% | Truist Securities | $28 → $24 | Maintains | Hold |
| 07/13/2023 | 41.84% | Truist Securities | $26 → $28 | Maintains | Hold |
| 05/10/2023 | 31.71% | Truist Securities | $24 → $26 | Maintains | Hold |
| 04/13/2023 | 21.58% | Truist Securities | $22 → $24 | Maintains | Hold |
| 02/23/2023 | 11.45% | Truist Securities | $17 → $22 | Maintains | Hold |
| 06/22/2022 | 36.78% | Truist Securities | $34 → $27 | Maintains | Hold |
| 11/23/2021 | — | HSBC | Initiates Coverage On | → Hold | |
| 11/17/2021 | 77.3% | RBC Capital | $42 → $35 | Maintains | Sector Perform |
| 11/11/2021 | — | Jefferies | Upgrades | Underperform → Hold | |
| 05/21/2020 | 143.16% | SunTrust Robinson Humphrey | $46 → $48 | Maintains | Buy |
| 05/11/2020 | 133.03% | SunTrust Robinson Humphrey | $42 → $46 | Maintains | Buy |
| 04/13/2020 | 112.77% | SunTrust Robinson Humphrey | $46 → $42 | Maintains | Buy |
| 02/21/2020 | 133.03% | CFRA | $38 → $46 | Upgrades | Hold → Buy |
| 01/21/2020 | — | Jefferies | Upgrades | Hold → Buy | |
| 10/23/2019 | — | Redburn Partners | Downgrades | Buy → Neutral | |
| 08/01/2019 | — | BTIG | Downgrades | Buy → Neutral | |
| 06/20/2019 | — | Barclays | Upgrades | Equal-Weight → Overweight |
What is the target price for Fresenius Medical Care (FMS)?
The latest price target for Fresenius Medical Care (NYSE: FMS) was reported by HSBC on November 24, 2023. The analyst firm set a price target for $0.00 expecting FMS to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fresenius Medical Care (FMS)?
The latest analyst rating for Fresenius Medical Care (NYSE: FMS) was provided by HSBC, and Fresenius Medical Care upgraded their hold rating.
When is the next analyst rating going to be posted or updated for Fresenius Medical Care (FMS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fresenius Medical Care, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fresenius Medical Care was filed on November 24, 2023 so you should expect the next rating to be made available sometime around November 24, 2024.
Is the Analyst Rating Fresenius Medical Care (FMS) correct?
While ratings are subjective and will change, the latest Fresenius Medical Care (FMS) rating was a upgraded with a price target of $0.00 to $0.00. The current price Fresenius Medical Care (FMS) is trading at is $19.74, which is out of the analyst's predicted range.